Factors Associated With Chemoradiation Therapy Interruption and Noncompletion Among Patients With Squamous Cell Anal Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Factors Associated With Chemoradiation Therapy Interruption and Noncompletion Among Patients With Squamous Cell Anal Carcinoma

Published:2020-06-01 Issue:6 Volume:6 Page:881
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Raphael Michael J.¹²,Ko Gary²,Booth Christopher M.²³⁴,Brogly Susan B.⁴⁵,Li Wenbin⁴,Kalyvas Maria²⁶,Hanna Timothy P.²⁴⁶,Patel Sunil V.²⁴⁵

Affiliation:

1. Sunnybrook Health Sciences Centre, Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada

2. Division of Cancer Care and Epidemiology, Queen’s Cancer Research Institute, Kingston, Ontario, Canada

3. Division of Medical Oncology, Department of Oncology, Queen’s University, Kingston, Ontario, Canada

4. International Credential Evaluation Service, Queen’s, Kingston, Ontario, Canada

5. Department of Surgery, Queen’s University, Kingston, Ontario, Canada

6. Division of Radiation Oncology, Department of Oncology, Queen’s University, Kingston, Ontario, Canada

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2764903/jamaoncology_raphael_2020_oi_200013.pdf

Reference27 articles.

1. Changing patterns of anal canal carcinoma in the United States.;Nelson;J Clin Oncol,2013

2. Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.;Benson;J Natl Compr Canc Netw,2018

3. Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.;Glynne-Jones;Eur J Surg Oncol,2014

4. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin.;UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research;Lancet,1996

5. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.;Bartelink;J Clin Oncol,1997

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sociodemographic and geographic factors impacting radiotherapy recommendation, initiation, and completion for patients with cancer;Cancer;2024-09-04

2. Using Nerve Blocks for Addressing Radiation-Induced Pain During Pelvic Cancer Treatment;JAMA Oncology;2024-06-01

3. Assessing Circulating Tumour DNA (ctDNA) as a Biomarker for Anal Cancer Management: A Systematic Review;International Journal of Molecular Sciences;2024-04-03

4. Capecitabine/cisplatin combined with concurrent intensity-modulated radiation therapy: a feasible therapeutic strategy for anal squamous cell carcinoma;Clinical and Translational Oncology;2023-08-11

5. The Association of Oxaliplatin-Containing Adjuvant Chemotherapy Duration with Overall and Cancer-Specific Mortality in Individuals with Stage III Colon Cancer: A Population-Based Retrospective Cohort Study;Current Oncology;2023-07-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3